(Q57302665)

English

Long-term anticoagulant effects ofCYP2C9andVKORC1genotypes in phenprocoumon users

No description defined

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

0 references

title

Long-term anticoagulant effects ofCYP2C9andVKORC1genotypes in phenprocoumon users (English)

0 references

1 reference

1 reference

T. I. VERHOEF

1

0 references

W. K. REDEKOP

series ordinal

2

0 references

H. HEGAZY

series ordinal

3

0 references

A. DE BOER

series ordinal

4

0 references

A. H. MAITLAND-van der ZEE

series ordinal

5

0 references

publication date

December 2012

0 references

published in

Journal of Thrombosis and Haemostasis

0 references

volume

10

0 references

issue

12

0 references

page(s)

2610-2612

0 references

cites work

Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJTH.12007

retrieved

21 January 2018

The largest prospective warfarin-treated cohort supports genetic forecasting

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJTH.12007

retrieved

21 January 2018

Pharmacogenetics of oral anticoagulant therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJTH.12007

retrieved

21 January 2018

Long-term anticoagulant effects of the CYP2C9 and VKORC1 genotypes in acenocoumarol users

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJTH.12007

retrieved

21 January 2018

Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJTH.12007

retrieved

21 January 2018

Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJTH.12007

retrieved

21 January 2018

Statistical design of personalized medicine interventions: The Clarification of Optimal Anticoagulation through Genetics (COAG) trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJTH.12007

retrieved

21 January 2018

Identifiers

DOI

10.1111/JTH.12007

0 references

PubMed publication ID

23016521

0 references

(Q57302665)

Long-term anticoagulant effects ofCYP2C9andVKORC1genotypes in phenprocoumon users

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)